Compare Bio Protocol (BIO) vs DeFi (DEFI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs DeFi — how do they compare? Bio Protocol trades at Rp434.19 (market cap Rp986,63M, Rp162,5M 24h volume), while DeFi trades at Rp13.17 (market cap Rp19,87M, Rp6,62M 24h volume). The key difference: Bio Protocol is far larger — about 49.7× DeFi's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 1,7B / 3B DEFI (59%) for DeFi. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and DeFi for 7 Days on average.
| BIO | DEFI | |
|---|---|---|
Market Cap | Rp986,63M | Rp19,87M |
Volume (24h) | Rp162,5M | Rp6,62M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 1,7B / 3B DEFI (59%) |
Typical Hold Time | 18 Days | 7 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
DEFI token exhibits a market cap of Rp19.87 million with 59% of its max supply in circulation, indicating moderate token distribution. Recent news highlights Bitcoin ETF closures and regulatory developments, indirectly affecting DeFi sentiment. Technical metrics are unavailable, but the crypto market faces volatility from ETF outflows and regulatory uncertainty.
Overall outlook is cautious due to low market cap and external pressures from Bitcoin's downturn. Key opportunities include potential DeFi adoption growth, while major risks involve liquidity constraints and regulatory shifts. Investors should monitor on-chain activity for signs of recovery.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About DeFi
DeFi is a Web3 antivirus and SocialFi super app that has been protecting users from scams and bad actors since its launch in July 2020. By 2023, the platform grew to over 5 million users, tracking $25 billion in user funds. Its DeFi Antivirus has already secured over $1.2 billion from potential losses, while providing leading portfolio-tracking and security solutions.
Read more on DEFI →
